RecruitingPhase 4NCT07221877
A Study to Evaluate the Effect of KarXT on Urological Safety
Sponsor: Bristol-Myers Squibb
Philadelphia, PA · +15 more sites
Schizophrenia clinical trials in Philadelphia, PA
9 recruiting schizophrenia studies with a site in Philadelphia, PA.
RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Philadelphia, PA · +44 more sites
RecruitingPhase 2NCT07410507
A Study of Brenipatide in Adult Participants With Schizophrenia
Sponsor: Eli Lilly and Company
Philadelphia, PA · +31 more sites
RecruitingPhase 3NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Philadelphia, PA · +49 more sites
RecruitingPhase 3NCT07369154
52-week Open Label Safety-Tolerability Study
Sponsor: LB Pharmaceuticals Inc.
Philadelphia, PA · +22 more sites
RecruitingPhase not listedNCT07379827
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Sponsor: Bristol-Myers Squibb
Philadelphia, PA · State College, PA · +53 more sites
RecruitingNot applicableNCT06700902
Taking Action for College Students
Sponsor: Temple University
Philadelphia, PA
RecruitingPhase 4NCT03495024
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Sponsor: Corporal Michael J. Crescenz VA Medical Center
Philadelphia, PA
Not yet recruitingNot applicableNCT07593456
NST-SPARK Open-Label Phase 1 STTR (IGNITE)
Sponsor: North Shore Therapeutics, Inc.
Philadelphia, PA · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.